Hoth Therapeutics (HOTH) : 5-year performance

Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne.

• Sector: Healthcare
• Industry: Biotechnology
• Full Time Employees: 2
• Founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017
• Headquartered in New York, New York
• https://hoththerapeutics.com

ticker:  HOTH